151 Medical Devices and 7 Clinical Trials were approved

In a statement issued on June 4, 2023, in Mexico City, the Federal Commission for Protection against Health Risks(COFEPRIS – Federal Commission for the Protection against Sanitary Risks – Regulatory Agency of Mexico) reported that, according to the most recent Biweekly Therapeutic Expansion Report, authorizations have been granted for a total of 179 health inputs, encompassing the categories of drugs, medical devices, and clinical trials. One relevant clinical trial was conducted to evaluate a drug intended for the treatment of acute lymphoblastic leukemia. Read more here

ELS can help in the investigation and research of all types of medical devices in Europe and LATAM.

Please contact your ELS local consultant or through the email: info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.